Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Trial ID or NCT#

NCT01827046

Status

not recruiting iconNOT RECRUITING

Purpose

A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).

Official Title

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

Investigator(s)

Gordon Li, MD
Gordon Li, MD
Neurosurgeon
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Ciara Harraher, MD

Contact us to find out if this trial is right for you.

Contact

Madelleine Garcia
650-723-4448